These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 31152823)

  • 1. From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.
    Caspa Gokulan R; Garcia-Buitrago MT; Zaika AI
    Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):37-48. PubMed ID: 31152823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disintegrin and metalloproteinases (ADAMs) expression in gastroesophageal reflux disease and in esophageal adenocarcinoma.
    Kauttu T; Mustonen H; Vainionpää S; Krogerus L; Ilonen I; Räsänen J; Salo J; Puolakkainen P
    Clin Transl Oncol; 2017 Jan; 19(1):58-66. PubMed ID: 27026568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutively Higher Level of GSTT2 in Esophageal Tissues From African Americans Protects Cells Against DNA Damage.
    Ferrer-Torres D; Nancarrow DJ; Steinberg H; Wang Z; Kuick R; Weh KM; Mills RE; Ray D; Ray P; Lin J; Chang AC; Reddy RM; Orringer MB; Canto MI; Shaheen NJ; Kresty LA; Chak A; Wang TD; Rubenstein JH; Beer DG
    Gastroenterology; 2019 Apr; 156(5):1404-1415. PubMed ID: 30578782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential MicroRNA Signatures in the Pathogenesis of Barrett's Esophagus.
    Craig MP; Rajakaruna S; Paliy O; Sajjad M; Madhavan S; Reddy N; Zhang J; Bottomley M; Agrawal S; Kadakia MP
    Clin Transl Gastroenterol; 2020 Jan; 11(1):e00125. PubMed ID: 31934893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative, tissue-specific analysis of cyclooxygenase gene expression in the pathogenesis of Barrett's adenocarcinoma.
    Kuramochi H; Vallböhmer D; Uchida K; Schneider S; Hamoui N; Shimizu D; Chandrasoma PT; DeMeester TR; Danenberg KD; Danenberg PV; Peters JH
    J Gastrointest Surg; 2004 Dec; 8(8):1007-16; discussion 1016-7. PubMed ID: 15585388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
    Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC
    Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
    Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
    Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma.
    Kaz AM; Grady WM; Stachler MD; Bass AJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):473-89. PubMed ID: 26021206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of Genes Related to Function and Metabolism of Vitamin D in Esophageal Adenocarcinoma.
    Singhal S; Kapoor H; Subramanian S; Agrawal DK; Mittal SK
    J Gastrointest Cancer; 2019 Dec; 50(4):867-878. PubMed ID: 30187205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma.
    Fang Y; Chen X; Bajpai M; Verma A; Das KM; Souza RF; Garman KS; Donohoe CL; O'Farrell NJ; Reynolds JV; Dvorak K
    Ann N Y Acad Sci; 2013 Oct; 1300():187-199. PubMed ID: 24117642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
    Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
    Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Evolution of Metaplasia to Adenocarcinoma in the Esophagus.
    Grady WM; Yu M
    Dig Dis Sci; 2018 Aug; 63(8):2059-2069. PubMed ID: 29766388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.
    Schlottmann F; Molena D; Patti MG
    Updates Surg; 2018 Sep; 70(3):339-342. PubMed ID: 30039277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal abnormalities and novel disease-related regions in progression from Barrett's esophagus to esophageal adenocarcinoma.
    Akagi T; Ito T; Kato M; Jin Z; Cheng Y; Kan T; Yamamoto G; Olaru A; Kawamata N; Boult J; Soukiasian HJ; Miller CW; Ogawa S; Meltzer SJ; Koeffler HP
    Int J Cancer; 2009 Nov; 125(10):2349-59. PubMed ID: 19670330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular targets for treatment of Barrett's esophagus.
    Feagins LA; Souza RF
    Dis Esophagus; 2005; 18(2):75-86. PubMed ID: 16053481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barrett's Metaplasia Progression towards Esophageal Adenocarcinoma: An Attempt to Select a Panel of Molecular Sensors and to Reflect Clinical Alterations by Experimental Models.
    Korbut E; Krukowska K; Magierowski M
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.
    Dighe SG; Chen J; Yan L; He Q; Gharahkhani P; Onstad L; Levine DM; Palles C; Ye W; Gammon MD; Iyer PG; Anderson LA; Liu G; Wu AH; Dai JY; Chow WH; Risch HA; Lagergren J; Shaheen NJ; Bernstein L; Corley DA; Prenen H; deCaestecker J; MacDonald D; Moayyedi P; Barr H; Love SB; Chegwidden L; Attwood S; Watson P; Harrison R; Ott K; Moebus S; Venerito M; Lang H; Mayershofer R; Knapp M; Veits L; Gerges C; Weismüller J; Gockel I; Vashist Y; Nöthen MM; Izbicki JR; Manner H; Neuhaus H; Rösch T; Böhmer AC; Hölscher AH; Anders M; Pech O; Schumacher B; Schmidt C; Schmidt T; Noder T; Lorenz D; Vieth M; May A; Hess T; Kreuser N; Becker J; Ell C; Ambrosone CB; Moysich KB; MacGregor S; Tomlinson I; Whiteman DC; Jankowski J; Schumacher J; Vaughan TL; Madeleine MM; Hardie LJ; Buas MF
    Carcinogenesis; 2021 Apr; 42(3):369-377. PubMed ID: 33300568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett's esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors.
    Carrossini N; Meireles Da Costa N; Andrade-Barreto E; Sousa VPL; Nicolau-Neto P; Souza-Santos PT; Mansur GR; Wernersbach L; Bozza PT; Viola JPB; Ribeiro Pinto LF
    Sci Rep; 2021 Jan; 11(1):981. PubMed ID: 33441691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Content Imaging of Barrett's-Associated High-Grade Dysplasia Cells After siRNA Library Screening Reveals Acid-Responsive Regulators of Cellular Transitions.
    Phipps SM; Garry CE; Kamal S; Johnson JD; Gilmer J; Long A; Kelleher D; Duggan SP
    Cell Mol Gastroenterol Hepatol; 2020; 10(3):601-622. PubMed ID: 32416156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.